Clin2
NCT06154083Possibly a fitRecruiting

Comparing stimulation doses for IVF with genetic testing

Fertility

This trial tests two different intensities of ovarian stimulation for women undergoing IVF with genetic testing of embryos. It aims to see which approach leads to more healthy embryos ready for transfer.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
110 people
Ages
38 years to 42 years
Study type
Interventional

Who can take part

  • You have been trying to get pregnant and need IVF.
  • You are planning to test embryos for genetic health.
  • Your AMH level (a measure of egg reserve) is between 1.5 and 3.5 ng/ml.
  • Your body mass index (BMI) is between 18.5 and 30.
  • You do not have a severe male infertility factor requiring surgical sperm extraction.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07691073Not yet recruiting· Phase 4
Fertility drug for better embryos with genetic testing

This trial is studying whether a specific fertility medication (hMG) helps improve embryo quality during IVF when you are also doing genetic testing of embryos. It may help you have better embryos for transfer.

Sabadell, Barcelona
NCT07346235Not yet recruiting· Phase 3
Comparing two doses of fertility medication for IVF

This trial compares two doses of follicle-stimulating hormone (FSH) to find out which dose helps women with normal ovarian reserve have better IVF outcomes. It aims to improve the chances of a successful pregnancy.

Pristina
NCT05173597Recruiting
Real-world study of follitropin delta dosing in IVF

This study looks at how follitropin delta is used in real clinics to help women stimulate eggs for IVF or ICSI. It may help doctors fine-tune dosing by comparing outcomes in everyday practice.

Lübeck, Schleswig-Holstein
NCT07772375Not yet recruiting
Comparing two starting doses of follicle-stimulating hormone in IVF

This trial tests two different starting doses of a fertility drug (follicle-stimulating hormone, or FSH) during a specific IVF preparation method called PPOS. The goal is to see which dose leads to better egg development for women with good fertility prospects.

Ho Chi Minh City, Ho Chi Minh City
NCT07153367Recruiting· Phase 2
Study of a fixed dose of Rekovelle for IUI treatment

This trial tests a fixed dose of the hormone follitropin delta (Rekovelle) to stimulate the ovaries before intrauterine insemination (IUI). It aims to see if this approach works well for women with regular cycles who are starting IUI for the first time.

Bruges
NCT06995261Recruiting
Follitropin delta in a long hormone-suppression IVF cycle

This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.

Düsseldorf, North Rhine-Westphalia

Hear when a new Fertility trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.